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INTRODUCTION
The child who has diabetes is at increased risk for gastrointestinal disorders. In
addition to the typical stigmata of increased weight and round, robust-appearing
faces with chemical abnormalities of hypoglycemia, hypocalemia, and hyper-
bilirubinemia, the infant of a diabetic mother may have a microcolon which requires
immediate diagnosis and treatment. Although these disorders complicate the neona-
tal period, they resolve rapidly and later in life, the liver, intestine, and pancreas
may each be affected in the child who developsjuvenile diabetes. Celiac disease and
cystic fibrosis are common disorders in the pediatric patient and have an increased
association with diabetes. A currently popular dietary measure in children with
diabetes, the use of"sugarless candy," may result in diarrhea. This article will famil-
iarize the clinician with these associations and allow a more knowledgeable
approach to the gastrointestinal problems of the child with diabetes.
PATHOGENESIS OF JUVENILE DIABETES
The pathogenesis ofjuvenile-onset diabetes is thought to be different from that of
maturity-onset diabetes. Juvenile-onset diabetes occurs in a younger age group, the
onset is more abrupt, patients require insulin administration early in the course of
the disease, and a seasonal incidence has been suggested. In a large number of
patients with juvenile diabetes, especially early on in the course of the disease,
inflammatory cells are seen to collect around the islets of Langerhans [1]. All of
these factors have prompted speculation about the temporal relationship to a viral
infection. A number of reports have identified a relationship between the onset of a
viral infection such as mumps and the subsequent development of diabetes [2].
There are case reports noting culture of rubella virus from the pancreas of a patient
who has contracted diabetes [3]. Recently, a coxsackie B4 virus was identified in the
pancreas of a 10-year-old child who developed diabetic ketoacidosis [4] and there
have been reports of increased titers to coxsackie viral infections in patients with
195
Copyright © 1983 by The Yale Journal of Biology anid Medicine, Inic.
All rights of reproduction in any form reserved.HILLEMEIER AND GRYBOSKI
diabetes [5]. The issue clearly requires further study, but it remains possible that a
number of patients with juvenile diabetes may be manifesting endocrine pancreatic
insufficiency as the sequela to a viral pancreatitis.
There are also reasons to promote an autoimmune phenomena as the basis for
juvenile diabetes mellitus [6]. Inflammatory cells around the islets are consistent
with an autoimmune process and several autoimmune disorders (i.e., Hashimotis,
thyroiditis, juvenile rheumatoid arthritis) are associated with insulin-dependent
diabetics. Antibodies to pancreatic islet cells, as well as several other body organs,
can be demonstrated in many newly diagnosed juvenile diabetics. Cell-mediated
immunity to the pancreas can also be demonstrated in many patients [7,8].
There is a definite genetic predisposition to the development of juvenile diabetes.
The strongest HLA associations for patients with juvenile diabetes are seen with
DRW3 and/or DRW4 cell surface antigens. The presence of DRW3 increases the
risk of developing juvenile-onset diabetes mellitus 3.8 times [9].
THE PANCREAS AND JUVENILE DIABETES
Acute Pancreatitis
Pancreatitis is not a common cause of abdominal pain in the pediatric age group.
There is some evidence to suggest, however, that the incidence of pancreatitis is in-
creased in the patient with juvenile diabetes, and it should be considered in the dif-
ferential diagnosis of any patient presenting with ketoacidosis with abdominal pain
that does not resolve appropriately in the course of medical management [10].
The child with diabetic ketoacidosis often presents with abdominal pain that is not
associated with pancreatitis. This pain is generalized in location. The abdomen may
be mildly tender to deep palpation but should not be rigid or exhibit rebound
tenderness. The child in diabetic ketoacidosis may have a partial ileus resulting in
nausea and vomiting, which may require placement of an NG tube. The gastroin-
testinal manifestations of diabetic ketoacidosis should subside within six hours after
the institution of intravenous fluid administration, correction of electrolyte abnor-
malities, and insulin therapy.
The child who has acute pancreatis in addition to his diabetic ketoacidosis may
give a history of a more sudden onset of abdominal pain. The pain is usually much
more severe in the upper abdomen and may be associated with extreme tenderness,
rigidity, and often rebound tenderness. Nausea and vomiting are often present in the
child with pancreatitis.
The diagnosis of acute pancreatitis can be confirmed by elevated serum amylase
and lipase levels. Amylase levels rise most rapidly and lipase levels often do not in-
crease for 24-48 hours. The urinary amylase-to-creatinine clearance ratio may not
be as helpful in the diagnosis of acute pancreatitis in the patient with juvenile dia-
betes, as it may also be elevated in diabetic ketoacidosis. Patients with acute pan-
creatitis are also likely to have increased leukocyte count, fever, decreased serum
calcium, and are likely to become volume-depleted very rapidly. In the patient where
laboratory values are equivocal, a flat plate of the abdomen may reveal the sentinel
loop typical of pancreatitis, or ultrasound may reveal inflammation within the body
of the pancreas.
The tendency of the patient with acute pancreatitis to become volume-depleted in
addition to the dehydration secondary to the ketoacidosis makes him at high risk.
Treatment ofpancreatitis andjuvenile diabetes mellitus with or without ketoacidosis
consists of prompt parenteral fluid administration and insulin therapy. Patients
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should be made NPO, have nasogastric suction placed, and will often require
analgesia for treatment ofthe pancreatitis. We do not recommend prophylactic anti-
biotics for the patient with pancreatitis. The patient should be kept NPO until reso-
lution of the pancreatitis is indicated by return of serum amylase and lipase to near
normal values. Patients with complicated or prolonged courses ofpancreatitis must
be followed carefully by ultrasound in order to detect the formation ofa pseudocyst
or abscess, which may require surgical intervention.
Pancreatic Insufficiency
With the exception ofcystic fibrosis, pancreatic insufficiency is extremely uncom-
mon in the pediatric age group. Although there have been isolated case reports of
idiopathic, clinically detected pancreatic insufficiency in children with growth
failure who have later developed diabetes, it is extremely uncommon to have clinical
evidence of pancreatic insufficiency in a child with juvenile diabetes [11].
Even though it is rarely a clinical problem, studies to quantitate pancreatic func-
tion in terms ofbicarbonate, trypsin, and amylase secretions have shown significant
loss of exocrine pancreatic function in 80 percent ofpatients who have hadjuvenile
diabetes for five years [12]. The longer the duration of juvenile diabetes, the more
severe the exocrine pancreatic dysfunction. It is possible that the exocrine pancreatic
dysfunction is a result ofprogressive structural damage tothe diabetic pancreas. The
pancreas in juvenile diabetes is sometimes atrophic, infiltrated with fat, and inflam-
matory infiltrates have become observed throughout the pancreas. Another con-
tributing factor may be that insulin is necessary to regulate the synthesis of pan-
creatic amylase and the lack of insulin's trophic effect may result in a decrease of
pancreatic enzymes.
THE LIVER AND JUVENILE DIABETES
Over 50 years ago Mauriac's syndrome was described, in which juvenile diabetics
had dwarfism, hepatosplenomegaly, and obesity [13]. The hepatosplenomegaly was
quite striking and often extended into the pelvis. The syndrome is seen exclusively in
patients with extremely poor control of their diabetes. Current developments in in-
sulin therapy which allow a more physiologic control of glucose homeostasis have
made the occurrence of this syndrome extremely rare. It has been suggested that in
Mauriac's syndrome the hepatomegaly is secondary to increased glycogen and/or
lipid storage [14]. Recent data suggest that the poor growth and dwarfism seen in
these patients may be related to low somatomedin levels which are improved by a
more physiologic control of glucose levels [15].
Clinically, liver disease is rarely a problem in the juvenile diabetic; however, if
careful attention is paid to the histology ofthe liver, alarge number ofabnormalities
may be found. In addition to revealing amounts of fat and glycogen infiltration
which seem to correlate with metabolic control, evidence of acute and chronic in-
flammation has been reported in a large percentage of patients [16].
JUVENILE DIABETES AND THE INTESTINAL TRACT
Most children with juvenile diabetes have normally appearing intestinal villous
structure on examination by light microscopy. Diabetic gastroenteropathy, a syn-
drome of intermittent or persistent diarrhea with or without steatorrhea, is usually
associated with a moderate to severe neuropathy and is seen in patients with long-
standing diabetes [17]. This condition is rarely seen during childhood.
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The examination of the small intestinal epithelium by special fat stains has re-
vealed an increased amount of lipid in diabetic children when compared to normal
controls [18]. It is not certain whether this is secondary to a defective clearing of ex-
ogenously absorbed lipid due to abnormal villous contracture, or due to markedly
increased endogenous synthesis of lipid. It has been speculated that a defect oflipid
clearance may be an early manifestation ofautonomic neuropathy, which would be
the precursor of the diabetic gastroenteropathy seen in long-standing diabetics [19].
There appears to be no relationship between the degree of accumulation of lipid in
the intestinal mucosa and the duration of the diabetes or the subjective gastro-
intestinal symptomatology such as abdominal pain. The amount of lipid present in
the small intestine appears to correlate most closely with the quality ofcontrol ofthe
diabetes [18].
THE SMALL LEFT COLON SYNDROME
The small left colon syndrome (SLCS) was first described in 1974 and later pur-
sued in detail by Stewart et al. [20]. It occurs in infants born to diabetic mothers,
most of whom are insulin-dependent. There is often a prenatal history of maternal
toxemia or polyhydramnios and the infants are born betwen 36 and 40 weeks of
gestation. Birth weights have varied between 2,400 and 4,500 g. Not all babies are
symptomatic, and up to 40 percent of infants born to diabetic mothers have
radiologic evidence of this disease. Initially there is respiratory distress and evidence
of hypoglycemic cardiomyopathy, persistent fetal circulation, and abdominal
distension. They fail to pass meconium by48 hours. The disease is a formidable one,
for 50 to 75 percent ofinfants reported have had intestinal perforation, and the mor-
tality may be as high as 50 percent. Radiologic study shows dilated loops of small
bowel and right colon, suggesting distal colonic obstruction. Barium enema shows
decreased caliber ofthe colon from the anus to the splenic flexurewith a longtransi-
tion zone. The colon proximal to the area of obstruction is dilated and fills easily
with barium. Pathologic studies show an increase in the ratio of small cells to
multipolar ganglion cells in both right and left colonic tissue. It has been suggested
that the etiology lies in an abnormal glucagon response to neonatal hypoglycemia,
for the high glucagon levels are not influenced by intravenous glucose [21]. It is pro-
posed that the increased glucagon inhibits gastrointestinal motility, particularly in
the jejunum and in the sigmoid. It is also possible that the immature ganglion cells
are unable to respond to normal sympathetic stimulation.
A Gastrografin or Hypaque enema is both diagnostic and therapeutic, but several
enemas may be required. Perforations occur in those symptomatic for 24 hours
before treatment.
JUVENILE DIABETES MELLITUS AND CELIAC DISEASE
It appears that children who havejuvenile diabetes mellitus are at increased risk to
suffer celiac disease [22]. There seems to be a genetic predisposition to both celiac
disease and juvenile diabetes, with both sharing an increased incidence of certain
histocompatibility antigens such as HLA-B-8. Approximately 80 percent ofpatients
with celiac disease are positive for HLA-B-8 while only 20-30 percent of the normal
population is positive for this antigen [23]. During an eight-year period, 100 new
cases of celiac disease and 400 new cases of juvenile diabetes were reported at the
Hospital for Sick Children in Toronto. The occurrence ofjuvenile diabetes in 6 per-
cent of children with celiac disease and celiac disease in 1.57 percent of the children
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with diabetes was much higher than one would expect from the prevalence of these
disorders in the general population [24].
Celiac disease occurs in approximately 1 in 3,000 in the United States; this figure
varies throughout the world, reaching a high of 1:300 in western Ireland. The disease
appears to affect primarily Caucasians, although various ethnic groups have been
reported to have celiac disease [22].
The pathogenesis of celiac disease remains unclear, although it is known that
gluten, a complex germ protein molecule found in wheat and several other cereals,
has a toxic effect on small intestinal epithelium. This toxic effect on the small in-
testinal epithelium causes the malabsorption which is the hallmark of many of the
clinical stigmata of celiac disease.
Celiac disease is usually diagnosed in the pediatric age group between eight
months and two years presenting with steatorrhea and failure to thrive. It is worthy
of note that one can present with steatorrhea and not have diarrhea. A second group
of patients will present in the pediatric age group in early adolescence with short
stature and delayed sexual development. Diagnosis of celiac disease is suggested by
several laboratory parameters which indicate malabsorption. A decreased serum
carotene suggests fat malabsorption; a decreased RBC folic acid level will indicate
decreased small intestinal absorption of water-soluble vitamins; an abnormal xylose
absorption test will indicate impaired small intestinal function, anemia may indicate
iron deficiency, a prolonged prothrombin time may indicate hypoprothrombinemia
secondary to vitamin K malabsorption, and a 72-hour stool fat collection will reveal
less than 95 percent absorption of ingested fats. The diagnosis of celiac disease re-
quires a small bowel biopsy which reveals increased mototic activity in the glandular
epithelium, an inflammatory response in the lamina propria noted as a round cell
infiltrate; immature epithelial cells which may appear pseudostratified, cuboidal, or
even squamous; and a decreased villous-to-crypt ratio.
The elimination of gluten-containing products from the child's diet usually leads
to a rapid clinical response. Initially, restriction of lactose is advised for several
weeks until disaccharidase values return to normal and the child is less likely to have
lactose intolerance. It is essential that the child and family visit a well-trained
dietician or nutritionist initially and atyearly intervals. Even the most intelligent and
well-meaning parents are unable to keep up with constant changes that occur in
commercial foods.
JUVENILE DIABETES AND CYSTIC FIBROSIS
Cystic fibrosis is the most common cause of pancreatic insufficiency in the
pediatric age group, accounting for greater than 95 percent of such cases. The
primary etiology ofcystic fibrosis is unknown but the clinical manifestations ofpan-
creatic insufficiency and lung disease are secondary to thick tenacious mucous which
has abnormal viscosity. It is a genetically determined, autosomal recessive disorder,
which manifests itselfapproximately 1 in 2,000 Caucasian births. Most children with
cystic fibrosis are diagnosed in early childhood subsequent to evaluations for failure
to thrive, chronic diarrhea, or recurrent pneumonia. The diagnosis is made by an
elevated sweat chloride concentration which can be performed in any major
pediatric center.
At least 50 mg of sweat is needed for adequate analysis and a sweat chloride of60
meq/l or higher is diagnostic ofcystic fibrosis. Pancreatic insufficiency is present in
about 90 percent of infants with cystic fibrosis [25]. If a sweat collection is impos-
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sible to obtain, stool trypsin can be measured. Most infants' stools contain trypsin in
dilution of 1:100 but as transit time increases in older children the enzyme is de-
graded by colonic bacteria and is no longer present.
In 1962, when the association between cystic fibrosis and diabetes mellitus was
first noted, the incidence was approximately 1 to 130 patients. Since then the average
life expectancy of a patient with cystic fibrosis has greatly increased and the two
disorders are seen more commonly, especially in older patients with cystic fibrosis.
Recently as many as 75 percent of patients with cystic fibrosis had been reported
to have abnormal glucose tolerance tests. A group of adolescent males with rela-
tively mild cystic fibrosis were compared to healthy adolescent males and found to
have significantly impaired glucose tolerance and significantly lower serum
immunoreactive insulin levels during oral and intravenous glucose tolerance tests
(26]. This same study demonstrated that patients with cystic fibrosis were even more
sensitive than normals in the peripheral response to administered insulin, suggesting
that the impaired carbohydrate tolerance seen in cystic fibrosis is due to an impaired
insulin response to acarbohydrate load. The increased peripheral tissue sensitivity to
insulin may help explain why patients with cystic fibrosis and diabetes rarely have
problems with ketoacidosis.
This impaired insulin response in cystic fibrosis is not thought to be the same
disorder asjuvenile diabetes mellitus but rather secondary to disordered architecture
and fibrous replacement of pancreatic islets. Although at autopsy a patient with
cystic fibrosis may have renal lesions similar to those ofjuvenile diabetics, the dia-
betes usually has no effect on the longevity ofchildren with cystic fibrosis. The child
with cystic fibrosis and diabetes mellitus is not as difficult to control as the normal
juvenile diabetic.
The management of intestinal manifestations of cystic fibrosis requires pancreatic
enzyme replacement. Recently enteric-coated granules have become available and
allow pancreatic enzyme to be ingested in a much more palatable and efficient man-
ner. The pulmonary disease in cystic fibrosis requires management by a clinician
who specializes in this disorder.
Shwachmann's syndrome is a much less common syndrome occurring in the
pediatric age patient with manifestations of pancreatic insufficiency, normal sweat
electrolytes, short stature, and neutropenia. Although not the rule, diabetes mellitus
can occur in these patients [27].
JUVENILE DIABETES AND OSMOTIC DIARRHEA
In recent years the use of so-called sugarless candies and soft drinks has become
common. Many patients with juvenile diabetes include these products in their
dietary regimen for prophylaxis of dental caries. Sorbitol is the most commonly
used, so-called "sugarless" sugar; it is a naturally occurring sugar which may be
found in small quantities in fruits, vegetables, and berries. It is not metabolized by
the oral flora and is very slowly absorbed through the gastrointestinal tract. Because
of these very properties diarrhea may follow, after the ingestion of sufficient quan-
tities of these sugars. It has been demonstrated that many children can develop diar-
rhea after the ingestion of approximately 9 grams of Sorbitol. The diarrheal thresh-
old appears to be related to weight and this may be easily exceeded by the energetic
appetites of children. One pack of Sorbitol-containing mints can easily cause diar-
rhea in a young child [28].
200DIABETES AND GI DISEASE IN CHILDREN 201
REFERENCES
1. Robbins SL: Pathologic basis of disease. Philadelphia, WB Saunders Co, 1974, p 266
2. John AJ: Diabetes mellitus in children. J Pediatr 39:723-744, 1949
3. Johnson GH, Tudor RB: Diabetes mellitus and the congenital rubella syndrome. Amer J Dis Child
120:453, 1970
4. Cudworth AG, Gamble DR, White GBB: Aetiology ofjuvenile onset diabetes: a prospective study.
Lancet i:385-388, 1977
5. Yoon JW, Austin M, Onodera T, et al: Virus-induced diabetes mellitus. New Eng J Med 300:
1173-1179, 1979
6. Rudolf MC, Genel M, Tamborlane WV, et al: Juvenile rheumatoid arthritis in children with diabetes
mellitus. J Pediatr 99:519-524, 1981
7. Maclaren NK, Huang SW: Antibody to cultured human insulinoma cells in insulin-dependent dia-
betes. Lancet i:997, 1975
8. Maclaren NK, Huang SW: Insulin-dependent diabetes: a disease of auto-regression. Science 192:64,
1976
9. Dawset J, Svejgaard A: HLA and disease. Copenhagen, Munskgaard, 1977
10. Malone JI: Juvenile diabetes and acute pancreatitis. J Pediatr 85:825-827, 1975
11. Fisher S, Drash A: Idiopathic pancreatic insufficiency in a small child. Clinical Pediatrics 17:3,
297-299, 1978
12. Drier M, Sanders JH, Wormsley KG, et al: Exocrine pancreatic function in juvenile onset diabetes
mellitus. Gut 17:685-691, 1976
13. Mauriac P: Hepatomegalies de l'enfance avec troubles de la croissance et du metabolisme des
glucides. Paris Med 2:525, 1934
14. Guest GM: The mauriac syndrome- dwarfism, hepatomegaly, and obesity with juvenile diabetes.
Diabetes 2:415, 1953
15. Winter RJ, Phillips LS, Mordecai NK, et al: Somatomedin activity and diabetic control in children
with insulin-dependent diabetes. Diabetes 28:952-954, 1979
16. Lorenz G, Barenwald G: Histologic and electron microscopic liver changes in diabetic children. Acta
Hepato Gastroenterol 26:435-438, 1979
17. Katz LA, Spiro HM: Gastrointestinal manifestations of diabetes. New Eng J Med 275: 1350-1361,
1966
18. Bobo RC, Partin JC, Schubart WK, et al: Abnormal lipid accumulation within the small intestinal
mucosa of children with juvenile onset diabetes mellitus. Am J Dis Child 131:962-969, 1977
19. Whalen GE, Soergel KH, Geenen JE: Diabetic diarrhea: a clinical and pathological study.
Gastroenterology 56:1021-1032, 1969
20. Stewart DR, Nixon GW, Johnson DG, et al: Neonatal small left colon. Ann Surg 186:741, 1979
21. Luycky AS, Massi-Benedetti R, Falorni F, et al: Presence ofpancreatic glucogon in the portal plasma
of human neonates. Diabetologia 8:296, 1972
22. Walker-Smith J: Celiac disease. In Diseases of the small intestine in childhood. London, Pitman
Medical, 1979, pp 91-138
23. Stokes PL, Asquith P, Cooke WT: Genetics of celiac disease. Clin Gastol 2:547, 1973
24. Thain ME, Hamilton JR, Ehrlich RM: Coexistence of diabetes mellitus and celiac disease. J Pediatr
85:527-529, 1974
25. Gryboski JD, Walker AW: Gastrointestinal problems in the infant. Philadelphia, WB Saunders Co,
1983, p 397
26. Wilmhurst EG, Soldmer JS, Holsclaw DS, et al: Endogenous and exogenous insulin responses in pa-
tients with cystic fibrosis. Pediatrics 55:75-81, 1975
27. Silverman A, Roy C: Pediatric clinical gastroenterology. St Louis, CV Mosby Co, 1983, pp 837-840
28. Gryboski JD: Diarrhea from dietetic candy. New Eng J Med 275:718, 1966